Page last updated: 2024-09-02

procyanidin and ticlopidine

procyanidin has been researched along with ticlopidine in 1 studies

Compound Research Comparison

Studies
(procyanidin)
Trials
(procyanidin)
Recent Studies (post-2010)
(procyanidin)
Studies
(ticlopidine)
Trials
(ticlopidine)
Recent Studies (post-2010) (ticlopidine)
4,1161362,74710,2891,8934,671

Protein Interaction Comparison

ProteinTaxonomyprocyanidin (IC50)ticlopidine (IC50)
Alpha-2A adrenergic receptorHomo sapiens (human)0.382
Cytochrome P450 2D6Homo sapiens (human)6.2928
Alpha-2B adrenergic receptorHomo sapiens (human)0.304
Alpha-2C adrenergic receptorHomo sapiens (human)1.175
Cytochrome P450 2B6Homo sapiens (human)0.405
Cytochrome P450 2C19Homo sapiens (human)0.6678
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.426

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gusak, VK; Il'iushchenko, SV; Iurchuk, AIu; Rodin, IuV; Shtutin, AA1

Trials

1 trial(s) available for procyanidin and ticlopidine

ArticleYear
[Application of preparation endotelon in complex treatment of chronic arterial insufficiency of lower extremities].
    Klinichna khirurhiia, 2000, Issue:10

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arterial Occlusive Diseases; Aspirin; Biflavonoids; Catechin; Drug Therapy, Combination; Female; Humans; Ischemia; Leg; Male; Middle Aged; Platelet Aggregation Inhibitors; Proanthocyanidins; Ticlopidine; Treatment Outcome

2000